Table 3: Changes overtime in systolic blood pressure in the two groups of the studied cases.
G I (n = 50) | G II (n = 50) | P-value | ||
Systolic BP 0 | 145.40 ± 12.81 | 145.80 ± 12.47 | P 0-1 | 0.88 |
Systolic BP 1 | 134.30 ± 8.018 | 137.90 ± 8.21 | P 0-2 | 0.03 |
Systolic BP 2 | 126.46 ± 7.92 | 132.84 ± 6.69 | P 1-2 | 0.00 |
Paired difference0-1 & (P0-1) |
11.10 ± 10.12 0.00 |
7.90 ± 8.58 0.00 |
||
Paired difference0-2 & (P0-2) |
18.75 ± 9.87 0.00 |
11.48 ± 9.98 0.00 |
||
Paired difference1-2 & (P1-2) |
7.81 ± 6.99 0.00 |
4.09 ± 5.53 0.01 |
G I: group I (received NAC supplementation); G II: group II (received none of the supplement); 0 denotes the time of diagnosis of preeclampsia; 1 denotes the first follow up; after 4 weeks of treatment and 2 refers to the second follow up after 6 weeks of treatment. P-value is significant at ≤ 0.05.